Exchange: NASDAQ·Updated 04:20 PM EDT
NVCR logo

NVCR NovoCure Ltd

$17.64
$0.19
(1.07%)
Today
Closed $17.64
$0.00
(0.00%)
After Hours
EarningsOct 29
Mkt Cap$2.08B
Vol612,634.00

About NVCR

NovoCure Ltd. is an oncology company which engages in the development, manufacture, and commercialization of Optune for the treatment of a variety of solid tumors. Its platform is called the Tumor Treating Field which uses electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, the United Kingdom.
35

Bearish Sentiment

How do you feel about NVCR?

Advertisement|Remove ads.